Milan, Italy, January 14, 2015 β Newron Pharmaceuticals S.p.A. (βNewronβ), a research and development company focused on novel CNS and pain therapies, announced today the
The information on the following pages may be made available in the United States. By clicking on the link below, you agree that you are in the United States.
